PTPA and neoplasm: Mice bearing PLC5 xenografted tumors were treated with RT plus EMQA, which led to the most significant inhibition of the average tumor growth without affecting tolerability, and to downregulation of pAkt and PP2A reactivation in the xenografted tumors.